Cargando…
Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review
BACKGROUND: Autoimmune serologies are often obtained in the initial evaluation of uncharacterized interstitial lung disease (ILD). Whether this practice is helpful in delineating connective-tissue disease related ILD (CTD-ILD) is not well known. We assessed the frequency of incident CTD-ILD as detec...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568060/ https://www.ncbi.nlm.nih.gov/pubmed/28830432 http://dx.doi.org/10.1186/s12931-017-0644-4 |
_version_ | 1783258795715067904 |
---|---|
author | Alsumrain, Mohammad De Giacomi, Federica Mirza, Shireen Moua, Teng |
author_facet | Alsumrain, Mohammad De Giacomi, Federica Mirza, Shireen Moua, Teng |
author_sort | Alsumrain, Mohammad |
collection | PubMed |
description | BACKGROUND: Autoimmune serologies are often obtained in the initial evaluation of uncharacterized interstitial lung disease (ILD). Whether this practice is helpful in delineating connective-tissue disease related ILD (CTD-ILD) is not well known. We assessed the frequency of incident CTD-ILD as detected by autoimmune serology testing and presenting clinical signs and symptoms. METHODS: Consecutive patients seen at our institution over a four year period with newly diagnosed uncharacterized ILD and autoimmune serologic testing were included. Serologic assessment was performed as a standardized order set of 13 laboratory tests. Presenting demographics and clinical signs or symptoms suggestive of autoimmune disease were correlated with the presence or absence of positive serology studies and final CTD-ILD diagnoses. RESULTS: Overall prevalence of newly diagnosed CTD-ILD was 6.9% (42 of 605). Positive serology was seen in 35.2% (213 of 605) of screened ILD. CTD-ILD was diagnosed in 19.2% of those with positive serology, and 52.8% of those with both positive serology and suggestive clinical signs or symptoms. Only 1.4% of those with positive serology and negative review of systems were diagnosed with CTD-ILD. CTD-ILD diagnoses were made more frequently in younger patients ≤60 years with no diagnoses made after the age of 80 (P = 0.009). Positive serology in non-CTD-ILD cases did not appear to confer any survival advantage. CONCLUSIONS: The yield of autoimmune serology testing in uncharacterized ILD appears greatest in those with suggestive clinical signs or symptoms on presentation for CTD-ILD. |
format | Online Article Text |
id | pubmed-5568060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55680602017-08-29 Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review Alsumrain, Mohammad De Giacomi, Federica Mirza, Shireen Moua, Teng Respir Res Research BACKGROUND: Autoimmune serologies are often obtained in the initial evaluation of uncharacterized interstitial lung disease (ILD). Whether this practice is helpful in delineating connective-tissue disease related ILD (CTD-ILD) is not well known. We assessed the frequency of incident CTD-ILD as detected by autoimmune serology testing and presenting clinical signs and symptoms. METHODS: Consecutive patients seen at our institution over a four year period with newly diagnosed uncharacterized ILD and autoimmune serologic testing were included. Serologic assessment was performed as a standardized order set of 13 laboratory tests. Presenting demographics and clinical signs or symptoms suggestive of autoimmune disease were correlated with the presence or absence of positive serology studies and final CTD-ILD diagnoses. RESULTS: Overall prevalence of newly diagnosed CTD-ILD was 6.9% (42 of 605). Positive serology was seen in 35.2% (213 of 605) of screened ILD. CTD-ILD was diagnosed in 19.2% of those with positive serology, and 52.8% of those with both positive serology and suggestive clinical signs or symptoms. Only 1.4% of those with positive serology and negative review of systems were diagnosed with CTD-ILD. CTD-ILD diagnoses were made more frequently in younger patients ≤60 years with no diagnoses made after the age of 80 (P = 0.009). Positive serology in non-CTD-ILD cases did not appear to confer any survival advantage. CONCLUSIONS: The yield of autoimmune serology testing in uncharacterized ILD appears greatest in those with suggestive clinical signs or symptoms on presentation for CTD-ILD. BioMed Central 2017-08-23 2017 /pmc/articles/PMC5568060/ /pubmed/28830432 http://dx.doi.org/10.1186/s12931-017-0644-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Alsumrain, Mohammad De Giacomi, Federica Mirza, Shireen Moua, Teng Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review |
title | Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review |
title_full | Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review |
title_fullStr | Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review |
title_full_unstemmed | Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review |
title_short | Utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review |
title_sort | utility of autoimmune serology testing in the assessment of uncharacterized interstitial lung disease: a large retrospective cohort review |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568060/ https://www.ncbi.nlm.nih.gov/pubmed/28830432 http://dx.doi.org/10.1186/s12931-017-0644-4 |
work_keys_str_mv | AT alsumrainmohammad utilityofautoimmuneserologytestingintheassessmentofuncharacterizedinterstitiallungdiseasealargeretrospectivecohortreview AT degiacomifederica utilityofautoimmuneserologytestingintheassessmentofuncharacterizedinterstitiallungdiseasealargeretrospectivecohortreview AT mirzashireen utilityofautoimmuneserologytestingintheassessmentofuncharacterizedinterstitiallungdiseasealargeretrospectivecohortreview AT mouateng utilityofautoimmuneserologytestingintheassessmentofuncharacterizedinterstitiallungdiseasealargeretrospectivecohortreview |